investorscraft@gmail.com

Intrinsic ValueNeutech Group Limited (9616.HK)

Previous CloseHK$2.36
Intrinsic Value
Upside potential
Previous Close
HK$2.36

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Neutech Group Limited operates as a specialized education and healthcare services provider in China, leveraging a dual-segment approach to drive revenue. The company's core Education Business segment generates income through formal higher education programs, including bachelor's degrees and junior college diplomas, supplemented by educational resources and apprenticeship initiatives. This segment benefits from China's growing demand for digital talent development, positioning Neutech within the competitive private education sector that serves both traditional students and lifelong learners seeking professional upskilling. The Healthcare and Wellness Business segment diversifies revenue streams through medical services, wellness offerings, and medical device sales, creating synergies with educational operations while tapping into China's expanding healthcare market. This integrated approach allows Neutech to maintain a distinctive market position by combining education with practical healthcare applications, though it operates in regulated sectors subject to policy changes. The company's university operations provide stable enrollment-based income while its medical services offer additional growth channels in complementary service sectors.

Revenue Profitability And Efficiency

Neutech generated HKD 2.04 billion in revenue for FY2024 with strong profitability, achieving net income of HKD 465.6 million representing a 22.8% net margin. The company demonstrated solid cash generation with operating cash flow of HKD 702.4 million, significantly exceeding capital expenditures of HKD 244.4 million, indicating efficient conversion of earnings into operational liquidity.

Earnings Power And Capital Efficiency

The company exhibits robust earnings power with diluted EPS of HKD 0.72, supported by its dual-segment revenue model. Operating cash flow coverage of capital expenditures at approximately 2.9 times reflects effective capital deployment, though the education sector typically requires ongoing investment in facilities and educational technology to maintain competitive positioning.

Balance Sheet And Financial Health

Neutech maintains a strong liquidity position with HKD 1.66 billion in cash and equivalents, providing substantial financial flexibility. However, total debt of HKD 3.14 billion indicates leveraged operations, which is common in education infrastructure development, requiring careful monitoring of debt service capabilities given the capital-intensive nature of educational and healthcare facilities.

Growth Trends And Dividend Policy

The company demonstrates shareholder returns through a dividend per share of HKD 0.388, representing a payout ratio of approximately 54% based on EPS. This dividend policy suggests management's confidence in sustainable earnings while retaining capital for growth initiatives in both education and healthcare segments within China's evolving regulatory environment.

Valuation And Market Expectations

With a market capitalization of HKD 1.78 billion, the company trades at approximately 0.87 times revenue and 3.8 times net income. The low beta of 0.259 indicates relative stability compared to broader market movements, reflecting investor perception of defensive characteristics in education and healthcare services.

Strategic Advantages And Outlook

Neutech's integrated education-healthcare model provides diversification benefits and cross-segment synergies. The company's established university operations and healthcare services position it to benefit from China's ongoing emphasis on digital talent development and healthcare modernization, though regulatory changes in both sectors require careful navigation and adaptive strategy implementation.

Sources

Company annual reportHong Kong Stock Exchange filingsCompany description and financial data provided

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount